Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center
- PMID: 33230824
- DOI: 10.1002/jca.21857
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center
Abstract
Introduction: ABO-incompatible (ABOi) kidney transplantation, a well-established procedure, has good long-term results provided pretransplant desensitization that includes immunosuppression and apheresis.
Objective: To compare, within the first pretransplant apheresis session given to 29 ABOi kidney-transplant candidates, the effect on isoagglutinin titers (both IgG and IgM isotypes) of three modalities: centrifugation therapeutic plasmapheresis (cTP; n = 10), filtration TP (fTP; n = 9), and double-filtration plasmapheresis (DFPP; n = 10).
Results: The three groups were comparable according to baseline demographics. Treated plasma volumes were similar across the three groups, that is, 4111 ± 403 mL (cTP), 3861 ± 282 mL (fTP), and 3699 ± 820 mL (DFPP): that is, 54 ± 7, 53 ± 7, and 53 ± 10 mL/kg respectively. One session of centrifugation or filtration TP reduced IgG anti-A/anti-B isoagglutinin titer by ~4, whereas one DFPP session reduced it by ~2. One session of cTP reduced IgM anti-A isoagglutinin titer by a little less than 4, whereas fTP and DFPP sessions reduced it by ~3. There were no statistical differences across the three groups regarding isoagglutinin rebound (IgG and IgM). However, isoagglutinin IgG rebound was >4 dilutions for anti-B titers compared with ~2 dilutions for anti-A titers. The median decreases in IgG level were -3.9 g/L (DFPP), -5.9 g/L (cTP), and - 6.06 g/L (fTP) (p = ns). Median fibrinogen depletions were ~ 60% (fTP), 64% (DFPP), and 76% (cTP).
Conclusions: Isoagglutinin depletions within the first apheresis session were similar across cTP, fTP, and DFPP: this was numerically lower for DFPP.
Keywords: ABO incompatible; centrifugation plasmapheresis; double-filtration plasmapheresis; filtration plasmapheresis; kidney transplantation.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Nakanishi T, Suzuki N, Kuragano T, Nagasawa Y, Hasuike Y. Current topics in therapeutic plasmapheresis. Clin Exp Nephrol. 2014;18(1):41-49. https://doi.org/10.1007/s10157-013-0838-0.
-
- Alamartine E, Maillard N. Therapeutic plasma exchange in nephrology. Where it applies? Transfus Apher Sci. 2019;58(3):262-265. https://doi.org/10.1016/j.transci.2019.04.010.
-
- Hirano R, Namazuda K, Suemitsu J, Harashima T, Hirata N. Plasma separation using a membrane. Transfus Apher Sci. 2017;56(5):649-653. https://doi.org/10.1016/j.transci.2017.08.008.
-
- Maggioni S, Allal A, Kamar N, Hermelin M, Faubel E, Rostaing L. Immunoadsorption and hemodialysis as a tandem procedure: a single-center experience of more than 60. Int J Artif Organs. 2015;38(6):304-310. https://doi.org/10.5301/ijao.5000420.
-
- Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando). 2013;27(1):1-8. https://doi.org/10.1016/j.trre.2012.07.003.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous